Interactions of Nitrogen-Containing Xenobiotics with Monoamine Oxidase (MAO) Isozymes A and B: SAR Studies on MAO Substrates and Inhibitors-Reference-Cited by-同舟云学术

Interactions of Nitrogen-Containing Xenobiotics with Monoamine Oxidase (MAO) Isozymes A and B: SAR Studies on MAO Substrates and Inhibitors

Published:2001-07-20 Issue:9 Volume:14 Page:1139-1162
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Kalgutkar Amit S.¹,Dalvie Deepak K.¹,Castagnoli, Neal¹,Taylor Timothy J.¹

Affiliation:

1. Pharmacokinetics, Dynamics, and Metabolism Department, Pfizer Global Research and Development, Groton, Connecticut 06340, and Peters Center for the Study of Parkinson’s Disease, Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx010073b

Reference303 articles.

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative approaches to Alzheimer's therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system;Ageing Research Reviews;2024-06

2. Antidepressant-Like Activity and Molecular Docking Analysis of a Sesquiterpene Lactone Isolated from the Root Bark of Ximenia americana (L.);Evidence-Based Complementary and Alternative Medicine;2024-02-03

3. In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease;Drug Design, Development and Therapy;2024-01

4. A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023;Pharmaceuticals;2023-09-15

5. Activatable organic upconversion nanoprobe for bioimaging of monoamine oxidase B in Parkinson’s disease;Sensors and Actuators B: Chemical;2023-08